Avidity Biosciences, Inc. (RNAM) Free Cash Flow by Year
Avidity Biosciences, Inc. recorded an outflow of $663.8M in free cash flow in fiscal year 2025. This represents a decrease of 115.6% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Avidity Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RNAM Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RNAM Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Avidity Biosciences, Inc. financials
Frequently Asked Questions
What was Avidity Biosciences, Inc.'s free cash flow in fiscal year 2025?
Avidity Biosciences, Inc. recorded an outflow of $663.8M in free cash flow in fiscal year 2025.
How fast is Avidity Biosciences, Inc.'s free cash flow growing?
Avidity Biosciences, Inc. (RNAM) free cash flow fell by 115.6% year over year, from -$307.9M to -$663.8M in fiscal year 2025.
How has Avidity Biosciences, Inc.'s free cash flow changed over the years?
Across the 8 fiscal years this page covers, Avidity Biosciences, Inc. (RNAM) free cash flow went from -$9.7M in fiscal year 2018 to -$663.8M in fiscal year 2025.
What was Avidity Biosciences, Inc.'s free cash flow in the most recent quarter?
Avidity Biosciences, Inc. (RNAM) reported -$175.3M in free cash flow in Q4 2025. This represents a decrease of 68.9% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Avidity Biosciences, Inc. (RNAM) reported on that line in every period on record.